Clinical Trials
7 trialsNCT07205315 2026-05-27
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Grit Biotechnology
Phase EARLY_PHASE1 Recruiting
NCT06802146 2026-04-23
Early Intervention in High Risk CCUS
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT06886516 2026-04-15
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06398457 2025-09-26
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Recruiting
NCT02285738 2019-05-08
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT00212407 2018-11-02
New York Blood Center National Cord Blood Program
New York Blood Center
Phase EARLY_PHASE1 Terminated
NCT02805868 2016-10-24
Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Northwestern University
Phase EARLY_PHASE1 Withdrawn